Terns Pharmaceuticals’ treatment of chronic myelogenous leukemia was granted orphan status by the FDA, according to a post to the agency’s website.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on TERN:
- Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences
- Terns Pharmaceuticals Welcomes New CEO and Board Member
- Terns Pharmaceuticals Welcomes Amy Burroughs as CEO
- Terns Pharmaceuticals Reports Inducement Grants to New Chief Executive Officer Under Nasdaq Listing Rule 5635(C)(4)
- Terns Pharmaceuticals appoints Burroughs as CEO
